18 pharma companies' licenses cancelled: DCGI takes action for manufacturing spurious medicines in India

Licenses of 18 pharma companies have been cancelled for manufacturing spurious medicines following an inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 states, sources said on Thursday. Action has been taken on 70 companies in Himachal Pradesh and 45 in Uttarakhand and 23 in Madhya Pradesh during the government crackdown on companies manufacturing spurious medicines, official sources said.